239 results
Page 5 of 12
6-K
EX-99
4jqfeuxgx9
27 Mar 19
BioLineRx Announces Successful Engraftment Data
7:01am
6-K
EX-99
6jzjv
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
2wj2j3y7
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
g5wimrxm 83
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-99.1
iue46rfia xt
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-99
9snhoivea0c cg
11 Dec 18
BioLineRx Announces Initiation of Triple Combination Arm of
7:00am
6-K
EX-99
o7mkxbww0xo9nqn
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-99
ms1 huruez
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-99
qid4 pn4xyxtstp239
22 Oct 18
Current report (foreign)
7:00am
6-K
EX-99
vtqz4f8qy
19 Oct 18
BioLineRx Presents Top-Line Results from
7:00am
6-K
EX-10.2
wre94knpv3en60b 5p
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99.1
tdoxfy
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99
mwxxgclyy9
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am
6-K
EX-99
m6npo0jjgxwbr0d4c
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am
6-K
EX-99
ywe hsf6vuu
7 Aug 18
BioLineRx Announces Positive Results of Lead-in Period
7:00am
6-K
EX-99
lygcrjts j3t
1 Aug 18
Current report (foreign)
7:00am
6-K
EX-99
b7w9gg6s6 08r
22 May 18
BioLineRx Reports First Quarter 2018 Financial Results
7:00am
6-K
EX-99
h35rqtsae7 enh
17 May 18
BioLineRx Reports Results of Phase 2 Study
8:57am